Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Yang Feng 888 Capital Limited ICG Intchains Group Ltd 13G 13.8% 2y
WPGG 14 Investment Ltd. IV DCBO Docebo Inc. 13G/A 9.91% 2y
Radcliffe Capital Management, L.P. JUN Juniper II Corp. 13G/A 0% 2y
NOMURA HOLDINGS INC CTLT CATALENT, INC. 13G 6.4% 2y
MSD Partners, L.P. XPOF Xponential Fitness, Inc. 13G/A 9.99% 2y
METEORA CAPITAL, LLC BRLS Borealis Foods Inc. 13G/A 9.47% 2y
D. E. Shaw & Co., L.P. AMAM Ambrx Biopharma, Inc. Common Stock 13G/A 6.7% 2y
GLAZER CAPITAL, LLC KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares 13G/A 3.12% 2y
PRICE T ROWE ASSOCIATES INC /MD/ ETRN Equitrans Midstream Corporation Common Stock 13G/A 1.5% 2y
ARMISTICE CAPITAL, LLC AUPH Aurinia Pharmaceuticals Inc. 13G 6.64% 2y
Samarra Company Lmited VNET VNET Group, Inc. 13G/A 8.4% 2y
Exor N.V. HMY Harmony Gold Mining Co Ltd 13G/A 4.8% 2y
T. Rowe Price Investment Management, Inc. MIR Mirion Technologies, Inc. 13G 9.1% 2y
Paradigm Biocapital Advisors LP ACLX Arcellx, Inc. 13G/A 7% 2y
Long Focus Capital Management, LLC QMCO Quantum Corp 13G/A 9.6% 2y
(VOLUNTARY) Thad Beshears TRLV Trulieve Cannabis Corp. 13G/A 3.76% 2y
D. E. Shaw & Co., L.P. NIR Near Intelligence, Inc. Common Stock 13G/A 0.2% 2y
D. E. Shaw & Co., L.P. TRTL TortoiseEcofin Acquisition Corp. III 13G/A 4.9% 2y
PERCEPTIVE ADVISORS LLC APLT Applied Therapeutics, Inc. Common Stock 13G/A 5.9% 2y
CANADA PENSION PLAN INVESTMENT BOARD EQH Equitable Holdings, Inc. 13G 5.4% 2y
RA CAPITAL MANAGEMENT, L.P. PCVX Vaxcyte, Inc. 13G/A 9.99% 2y
Deep Track Capital, LP RLMD Relmada Therapeutics, Inc. 13G/A 6.79% 2y
Timothy Vanderhook DSP Viant Technology Inc. 13G 34.2% 2y
Rock Springs Capital Management LP TPST Tempest Therapeutics, Inc. 13G/A 0% 2y
Fundsmith LLP SABR Sabre Corp 13G/A 5.9% 2y
SIT INVESTMENT ASSOCIATES INC VTN Invesco Trust for Investment Grade New York Municipals 13G 6.41% 2y
PERCEPTIVE ADVISORS LLC BLPH Bellerophon Therapeutics, Inc. 13G/A 0% 2y
RTW INVESTMENTS, LP ESTA Establishment Labs Holdings Inc. 13G/A 9.7% 2y
BRAIDWELL LP CRNX Crinetics Pharmaceuticals, Inc. 13G/A 0% 2y
Roystone Management Holdings LLC BTMD biote Corp. 13G/A 9% 2y
Paradigm Biocapital Advisors LP VOR Vor Biopharma Inc. 13G/A 9.5% 2y
BRAIDWELL LP DCPH Deciphera Pharmaceuticals, Inc. Common Stock 13G/A 2.92% 2y
T. Rowe Price Investment Management, Inc. MGEE Mge Energy Inc 13G 5.7% 2y
K2 HealthVentures Equity Trust LLC CRBP Corbus Pharmaceuticals Holdings, Inc. 13G/A 7.5% 2y
Alger Associates, Inc. 13-3017981 ALAI Alger ETF Trust 13G/A 14.9% 2y
AWM Investment Company, Inc. RCAT Red Cat Holdings, Inc. 13G 6.7% 2y
BRAIDWELL LP DBVT DBV Technologies S.A. 13G/A 9.99% 2y
T. Rowe Price Investment Management, Inc. VSEC Vse Corp 13G 9.7% 2y
SAMLYN CAPITAL, LLC MRUS Merus N.V. Common Shares 13G 5.9% 2y
TANG CAPITAL MANAGEMENT, LLC EOLS Evolus, Inc. 13G/A 5.4% 2y
Boundary Creek Advisors LP MERC Mercer International Inc. 13G 8.5% 2y
EdgePoint Investment Group Inc. PSMT Pricesmart Inc 13G/A 8.9% 2y
Oaktree Capital Holdings, LLC BRY Berry Corporation (bry) Common Stock 13G/A 4.89% 2y
Redmile Group, LLC NGNE Neurogene Inc. 13G/A 8.1% 2y
Oates-Fairrington Kathryn Ruth FSBC Five Star Bancorp 13G/A 6.7% 2y
Cerberus Capital Management, L.P. ACI Albertsons Companies, Inc. 13G/A 26.4% 2y
T. Rowe Price Investment Management, Inc. USPH U S Physical Therapy Inc 13G 5.1% 2y
METEORA CAPITAL, LLC TCOA Zalatoris Acquisition Corp. 13G/A 13.8% 2y
ARMISTICE CAPITAL, LLC SLGL Sol-Gel Technologies Ltd. 13G 7.68% 2y
ArrowMark Colorado Holdings LLC PMVP PMV Pharmaceuticals, Inc. 13G 5.31% 2y